Strides Pharma Science Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹1,100.57Cr |
Net Profits | ₹49.67Cr |
Net Profit Margins | 4.51% |
Highlights
Revenue:
Strides Pharma Science Ltd’s revenue jumped 18.01% since last year same period to ₹1,100.57Cr in the Q3 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated 6.31% jump in its revenue since last 3-months.
Net Profits:
Strides Pharma Science Ltd’s net profit jumped 162.06% since last year same period to ₹49.67Cr in the Q3 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated 137.82% jump in its net profits since last 3-months.
Net Profit Margins:
Strides Pharma Science Ltd’s net profit margin jumped 152.59% since last year same period to 4.51% in the Q3 2023-2024. On a quarterly growth basis, Strides Pharma Science Ltd has generated 135.57% jump in its net profit margins since last 3-months.
